Ambulatory Blood Pressure Comparison of Amlodipine, Cilnidipine, and Azelnidipine in Hypertension: The AMCILAZ-EH Multicentre, Prospective, Observational Study.

Cureus · 2026 · PMC13319494 · PMID 42388547

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A numerically greater reduction in SBP was observed with amlodipine, although this did not reach statistical significance.

also in 111,027 other papers

a numerical trendno p-value reported

Pulse rate remained largely unchanged with all three drugs, although azelnidipine demonstrated a numerical trend toward greater pulse-rate reduction.

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.